Clal Biotechnology Industries Ltd. (TASE:CBI) announced that it has entered into an investment agreement for private placement of 1,506,000 common shares at ILS 3.32 per share for gross proceeds of ILS 4,999,920 on April 12, 2017. The transaction will include participation from four institutional investors. The company will also issue 1,004,000 unlisted warrants in the transaction. Each warrant is exercisable at ILS 3.70 for within 18 months and at ILS 4 per share between 18 months and 24 months. The investors will acquire about 1.01% stake in the company. The securities are subject to hold period of six months since allotment. The allotment of the shares is subject to Tel-Aviv Stock Exchange approval for the listing.